Navigation Links
New VSL#3® JUNIOR probiotic for children now available
Date:8/7/2012

GAITHERSBURG, MD, August 7, 2012 Sigma-Tau Pharmaceuticals, Inc., is excited to introduce a new probiotic medical food for children with IBS. A study published in the Journal of Pediatric Gastroenterology and Nutrition (1) , found that VSL#3, a high-potency probiotic medical food, provided a beneficial role in the dietary management of children who suffer from irritable bowel syndrome (IBS), a common problem for which there is no cure. This finding led Sigma-Tau, distributor of VSL#3, to develop and introduce new VSL#3 JUNIOR; a high-potency probiotic medical food for the dietary management of irritable bowel syndrome (IBS) and ulcerative colitis (UC) in children. New VSL#3 JUNIOR is now available through participating pharmacies behind the counter.

"One of the most obscure consequences of IBS in children is the way these conditions affect their entire family," expresses Mary Ocnean, senior product manager at Sigma-Tau Pharmaceuticals. "VSL#3 has been clinically proven to provide significant improvement in family life disruption scores and in reducing the discomfort and bloating of IBS. It is the first probiotic medical food that has been studied in a pediatric, randomized, double-blind, placebo-controlled crossover trial for children. It was a natural next step for us to extend the line of VSL#3 products with a pediatric version and we're happy to announce that it is now available to consumers in a once daily formulation," adds Ocnean.

Unlike other probiotics, VSL#3 JUNIOR is a medical food and requires refrigeration to preserve its 8 proprietary strains of 225 billion live bacteria, making it one of the few probiotics with this many strains and about 50 times more potent than the average probiotic (2) . VSL#3 JUNIOR is all-natural and comes in watermelon, a kid-pleasing flavor, making compliance less of an issue.

"There has been extensive clinical research in patients who added VSL#3 to their daily regimen, and the evidence shows that this probiotic plays a beneficial role in the dietary management of children suffering with IBS and UC (3) . IBS patients receiving VSL#3 also had significantly greater improvements versus both baseline and placebo in discomfort, bloating, gassiness and family assessment of life disruption (1). For young patients with UC, VSL#3 JUNIOR offers a tasty alternative to current VSL#3 products," says Ocnean. VSL#3 JUNIOR can be mixed into cold drinks, such as water and juice or foods like applesauce or ice cream, making it easy for children who find taking medication difficult. Adjustment of the intestinal flora can take a few days or weeks; it may take up to one month for the colonization of the gut to become optimally stable. All natural VSL#3 JUNIOR is gluten free, is Kosher and Halal certified, and a non-dairy product. Each box contains 30 watermelon flavored packets. As with all forms of VSL#3, they must be used under medical supervision.


'/>"/>
Contact: Nicole Egan
negan@rlapr.com
914-241-0086
Robin Leedy & Associates, Inc.
Source:Eurekalert

Related medicine news :

1. Probiotic Products May Prevent Antibiotic-Linked Diarrhea
2. Food hypersensitivity and otolaryngologic conditions in young children
3. Mothers, children underestimate obesity in China
4. Preschool children who can pay attention more likely to finish college
5. Adalimumab is a promising therapy for children with Crohns disease
6. Medical complications in hospitalized children: The Canadian Paediatric Adverse Events Study
7. Women and Children First? Not So, Says Study
8. Neglect May Harm Brain Growth in Children
9. Wayne State develops better understanding of memory retrieval between children and adults
10. Heavy Drinking in Pregnancy Linked to Host of Problems in Children
11. New lipid screening guidelines for children overly aggressive, UCSF researchers say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... Memorial ... for Graduate Medical Education (ACGME) that it has received accreditation for its residency ... of three residency programs that Memorial is currently pursuing, including Pediatrics and Internal ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Bernie Siegel, ... seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related to Death live on ... . Dr. Bernie Siegel, author of a plethora of essential books-to-read for ...
(Date:4/29/2016)... ... April 29, 2016 , ... Spine Team Texas, a ... proud to announce one of their physicians has been invited to be a featured ... ACOFP) Family Practice Review conference on April 30, 2016. , Dr. R. Scott ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. ... for the majority of skin cancer deaths. More than 10,000 people are expected to die ... diagnosis is 62, it is the one of the most commonly diagnosed cancers in young ...
(Date:4/29/2016)... ... 29, 2016 , ... Jvion, the market leader in clinical ... Eastside Partners, with participation from existing investor Martin Ventures. The funds will ... technology and product roadmap. , “Jvion is experiencing significant growth and ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... April 27, 2016  Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended March ... of $0.24 increased 41.2%, and non-GAAP diluted EPS ... increased 5.8% on a reported basis, and 6.3% ... "We posted another good quarter, highlighted by 14.6% ...
(Date:4/27/2016)... , April 27, 2016 ... Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor ... announced its sales for the first quarter ended March ... and the execution of its commercial strategy. ...
(Date:4/27/2016)... Conn. , April 27, 2016   ... of its digital health technology platform, which specializes ... and programs into scalable digital products, Zillion enables ... engagement and empower consumers to take control of ... face-to-face live video conferencing – including one-to-one, group ...
Breaking Medicine Technology: